177 results on '"Calvo‐Río, Vanesa"'
Search Results
2. Intravenous immunoglobulin therapy in antineutrophil cytoplasmic antibody-associated vasculitis
3. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study
4. ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis
5. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
6. Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
7. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
8. Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review
9. Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients
10. Long-term follow-up of certolizumab pegol in uveitis due to immunemediated inflammatory diseases: multicentre study of 80 patients.
11. Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review.
12. Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
13. Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes
14. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study
15. Brief Report: Association of HLA–DRB1*01 With IgA Vasculitis (Henoch-Schönlein)
16. Single-organ cutaneous small-vessel vasculitis according to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides: a study of 60 patients from a series of 766 cutaneous vasculitis cases
17. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet’s disease: a 1-year follow-up study of 124 patients
18. Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy
19. Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients
20. Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study
21. Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients
22. Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. National multicenter study of 51 cases in clinical practice.
23. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
24. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
25. SAT0219 EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS INDEPENDENTLY OF THE INICIAL PREDNISONE DOSE
26. FRI0269 COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHÇET’S DISEASE. NATIONAL MULTICENTER STUDY OF 177 CASES
27. AB0762 TREATMENT WITH TOFACITINIB IN REFRACTORY PSORIATIC ARTHRITIS. MULTICENTER STUDY OF CLINICAL PRACTICE
28. THU0566 OCULAR FEATURES IN 381 PATIENTS WITH SYSTEMIC SARCOIDOSIS AND ITS CORRELATION WITH THE IWOS CRITERIA. STUDY IN A UNIVERSITY HOSPITAL
29. SAT0235 BIOLOGICAL THERAPYIN NEUROBEHÇET. MULTICENTER STUDY OF 29 PATIENTS
30. FRI0277 ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB
31. FRI0276 TIME OF DISEASE EVOLUTION AND EFFICACY OF TOCILIZUMAB IN GIANT CELL ARTERITIS
32. FRI0202 SHORT AND LONG-TERM FOLLOW-UP OF APREMILAST THERAPY IN REFRACTORY SKIN LUPUS LESIONS
33. AB1077 ANTI-IL6-RECEPTOR TOCILIZUMAB IN GRAVES’ ORBITOPATHY. MULTICENTER STUDY OF 46 PATIENTS IN CLINICAL PRACTICE
34. THU0292 EXTRACRANIAL VESSEL INVOLVEMENT IN PATIENTS WITH GIANT CELL ARTERITIS
35. FRI0604 SYSTEMIC SARCOIDOSIS. STUDY OF 381 PATIENTS FROM A TERTIARY UNIVERSITY HOSPITAL IN THE NORTH OF SPAIN
36. THU0581 BIOLOGICAL THERAPY IN NON ISCHAEMIC OPTIC NEURITIS ASSOCIATED TO IMMUNE-MEDIATED INFLAMMATORY DISEASES. MULTICENTER STUDY
37. SAT0220 USE OF TOCILIZUMAB IN AORTITIS. A MULTICENTER STUDY OF 79 PATIENTS
38. OP0339 TOCILIZUMAB IN GIANT CELL ARTERITIS. MONOTHERAPY VERSUS COMBINED WITH CONVENTIONAL IMMUNOSUPPRESSIVE DRUGS
39. SAT0215 APREMILAST IN REFRACTORY ORAL AND/OR GENITAL ULCERS IN BEHÇET’S DISEASE. MULTICENTER STUDY OF 49 CASES IN CLINICAL PRACTICE
40. FRI0038 HERPES ZOSTER IN RHEUMATOID ARTHRITIS. PROSPECTIVE SINGLE CENTER STUDY OF 390 RA PATIENTS FOR 5YEARS
41. AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ADMINISTRACION: INTRAVENOUS OR SUBCUTANEOUS
42. FRI0270 APREMILAST IN NON-ULCER MANIFESTATIONS IN BEHçET’S DISEASE. MULTICENTER STUDY OF 32 CASES IN CLINICAL PRACTICE
43. THU0288 LONG-TERM FOLLOW-UP OF ANTI-IL6-RECEPTOR TOCILIZUMAB IN REFRACTORY UVEITIS IN PATIENTS WITH BEHÇET’S DISEASE. MULTICENTER STUDY OF 14 PATIENTS IN CLINICAL PRACTICE
44. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
45. Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica
46. Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
47. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
48. The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population
49. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study
50. Relapses in patients with Henoch–Schönlein purpura
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.